GlycoMimetics (GLYC) Stock Chart & Stock Price History $0.16 -0.01 (-6.63%) Closing price 06/13/2025Extended Trading$0.16 0.00 (0.00%) As of 06/13/2025 07:49 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock GlycoMimetics Stock Price Performance The GlycoMimetics (GLYC) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has decreased 99.44%, with a year-to-date return of -99.38%. In the past month, the stock has decreased 99.20%, reflecting recent market activity. As of the latest close, GlycoMimetics traded at $0.16 with a market cap of $10.00 million and volume of 1.05 million shares. Five years ago, the stock traded at a split-adjusted price of $375.00, representing a 99.96% decrease over that period. At the time, it had a market cap of $165.62 million and a volume of 5,789 shares. Receive GLYC Stock News and Ratings via EmailSign-up to receive the latest news and ratings for GlycoMimetics and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance0.00%1 Month Performance-99.20%3 Month Performance-99.16%Year-To-Date Performance-99.38%1 Year Performance-99.44%5 Year Performance-99.96% GLYC Stock Chart for Tuesday, July, 8, 2025 GLYC Chart by TradingView GlycoMimetics Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization07/07/2025$0.16$0.16$0.17$0.151.05 million shs$10.00 million07/04/2025$0.16$0.16$0.17$0.151.05 million shs$10.00 million07/03/2025$0.16$0.16$0.17$0.151.05 million shs$10.00 million07/02/2025$0.16$0.16$0.17$0.151.05 million shs$10.00 million07/01/2025$0.16$0.16$0.17$0.151.05 million shs$10.00 million06/30/2025$0.16$0.16$0.17$0.151.05 million shs$10.00 million06/27/2025$0.16$0.16$0.17$0.151.05 million shs$10.00 million06/26/2025$0.16$0.16$0.17$0.151.05 million shs$10.00 million06/25/2025$0.16$0.16$0.17$0.151.05 million shs$10.00 million06/24/2025$0.16$0.16$0.17$0.151.05 million shs$10.00 million Get the Latest News and Ratings for GLYC and Related StocksEnter your email address below to receive the latest news and analysts' ratings for GlycoMimetics and its competitors with MarketBeat's FREE daily newsletter. 06/23/2025$0.16$0.16$0.17$0.151.05 million shs$10.00 million06/20/2025$0.16$0.16$0.17$0.151.05 million shs$10.00 million06/19/2025$0.16$0.16$0.17$0.151.05 million shs$10.00 million06/18/2025$0.16$0.16$0.17$0.151.05 million shs$10.00 million06/17/2025$0.16$0.16$0.17$0.151.05 million shs$10.00 million06/16/2025$0.16$0.16-1.27%$0.17$0.151.05 million shs$10.00 million06/13/2025$16.60$15.70-5.42%$17.00$15.3010,497 shs$10.13 million06/12/2025$16.60$16.60$17.25$15.3518,535 shs$10.71 million06/11/2025$17.04$16.60-2.58%$17.91$16.0017,763 shs$10.71 million06/10/2025$17.66$17.04-3.51%$17.50$15.1517,794 shs$11.00 million06/09/2025$19.38$17.66-8.88%$18.40$17.2226,938 shs$11.40 million Related Companies Acrivon Therapeutics Stock Price Chart Eagle Pharmaceuticals Stock Price Chart Artiva Biotherapeutics Stock Price Chart Eliem Therapeutics Stock Price Chart Mersana Therapeutics Stock Price Chart Barinthus Biotherapeutics Stock Price Chart Shattuck Labs Stock Price Chart Iterum Therapeutics Stock Price Chart Karyopharm Therapeutics Stock Price Chart PepGen Stock Price Chart Receive GLYC Stock News and Ratings via EmailSign-up to receive the latest news and ratings for GlycoMimetics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:GLYC) was last updated on 7/8/2025 by MarketBeat.com Staff From Our PartnersEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredF1 Engineering Powers This Electric Marine MotorThe future of marine propulsion has arrived - powered by F-1 grade engineering. In collaboration with McLar...The Tomorrow Investor | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredInstant Cash (in 4 clicks)Since 1973, Wall Street has quietly used a strange little pricing quirk to cash flow billions. Now, for the...Awesomely, LLC | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | SponsoredForget Nvidia, This “Ghost Town” Company Holds the Key to the AI BoomCold War Discovery Could Unlock $100 Trillion in Wealth Jeff recently traveled to an American ghost town to...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding GlycoMimetics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share GlycoMimetics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.